The Era of Antibody Drug Conjugates in Lung Cancer: Trick or Threat?
{{output}}
Antibody Drug Conjugates (ADCs) are a novel class of therapeutics that structurally are composed by an antibody directed to a tumour epitope connected via a linker to a cytotoxic payload, and that have shown significant antitumor activity across a range of mal... ...
